Gross margin from €6,784 to €70,566Result from €4,299 to €51,481Registered office moved from Jette to Merchtem22-10Dividend €833Equity from €5,940 to €56,588Debts from €3,254 to €9,985
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 39,329 companies had the same profile as Dr. Margaux Vanderstraeten has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Micro
2 to 5 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,329 companies, not a prediction for Dr. Margaux Vanderstraeten. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered office moved from Jette to Merchtem
The registered office moved from Bonaventurestraat 120 bus 1, 1090 Jette to Oudstrijdersstraat 2/0011, 1785 Merchtem · General meeting of 10-10-2025 · Gazette deed
First establishment
At the time the registered office was still in Jette, Bonaventurestraat 120 bus 1.
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1013804408
Incorporation
Founding capital of €2,500, 25 shares · published on 23-09-2024 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Dr. Margaux Vanderstraeten: general medical practice (NACE 86210). They are comparable in size and age: total assets between €63,600 and €71,500, founded between 2024 and 2025.
Dr. Margaux Vanderstraeten has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €56,588 and a net result of €51,481.
Its solvency ranks better than 77% of 21,368 sector peers (NACE 86) in financial year 2025.
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. Margaux Vanderstraeten?
Dr. Margaux Vanderstraeten is a private limited company (BV).
When was Dr. Margaux Vanderstraeten founded?
Dr. Margaux Vanderstraeten was founded on 19-09-2024.
Is Dr. Margaux Vanderstraeten still active?
Yes, Dr. Margaux Vanderstraeten is an active enterprise in the KBO register.
What is the turnover of Dr. Margaux Vanderstraeten?
The turnover in financial year 2025 is ≈ €160,000. This figure is estimated from the gross margin of €70,566 and 33 comparable companies (NACE 862). It probably lies between €120,000 and €200,000.Financials
Is Dr. Margaux Vanderstraeten profitable?
In financial year 2025, Dr. Margaux Vanderstraeten made a profit of €51,481.
Where can I find the annual accounts of Dr. Margaux Vanderstraeten?
Dr. Margaux Vanderstraeten filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Margaux Vanderstraeten due?
Dr. Margaux Vanderstraeten must file the annual accounts for financial year 2026 by 31-07-2027.Timeline